...
首页> 外文期刊>Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology >Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia
【24h】

Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia

机译:澳大利亚使用导管消融治疗房颤的十年趋势与使用冠脉介入治疗缺血性心脏病的十年趋势

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AimsPercutaneous coronary intervention (PCI) and catheter ablation are well-accepted therapeutic interventions for treatment of coronary artery disease and atrial fibrillation (AF), respectively. We sought to examine temporal trends in the provision of these services over the past decade in Australia.Methods and resultsA retrospective review of the numbers of PCIs and AF ablations from 2000/01 to 2009/10 was performed on data from three sources: the Australian Institute of Health, Welfare and Aging (AIHW), Medicare Australia database (MA), and local records at a high volume tertiary referral centre (RMH) for AF ablation. Linear regression models were fitted comparing trends in population-adjusted procedural numbers over the 10-year period. There was a 5% per year population-adjusted increment in PCIs over 10 years from both the AIHW and MA sources, respectively (P < 0.001). This was similar to the growth rate of all cardiovascular procedures (AIHW: 5.1 vs. 3.8%/year, P = 0.27). Atrial fibrillation ablations showed a 30.9, 23.2, and 39.8% per year population-adjusted increment over 10 years from the AIHW, MA, and RMH sources respectively (P < 0.001 for all). Growth of AF ablations was significantly higher than PCIs (P < 0.001 for AIHW and MA sources) and all cardiovascular procedures (AIHW: 30.9 vs. 3.8%/year, P < 0.001).ConclusionThe provision of catheter-based AF ablation services in Australia has increased exponentially over the past decade. Its annual growth rate exceeded that of PCIs and all cardiovascular procedures. Given the increasing epidemic of AF, these data have critical implications for public health policy assessing the adequacy of infrastructure, training, and funding for AF ablation services.
机译:目的经皮冠状动脉介入治疗(PCI)和导管消融术是公认的分别用于治疗冠状动脉疾病和房颤(AF)的治疗性干预措施。我们试图研究过去十年澳大利亚在提供这些服务方面的时间趋势。方法和结果对来自2000/01至2009/10年间PCI和AF消融的数量进行了回顾性研究,其依据来自以下三个来源:澳大利亚卫生,福利和老龄化研究所(AIHW),澳大利亚Medicare数据库(MA)以及在大容量三级转诊中心(RMH)进行房颤消融的本地记录。拟合了线性回归模型,比较了十年期间人群调整后的手术数量趋势。 AIHW和MA的资料显示,在10年中,PCI的人口调整后每年递增5%(P <0.001)。这与所有心血管手术的增长率相似(AIHW:5.1 vs. 3.8%/年,P = 0.27)。心房纤颤消融显示,AIHW,MA和RMH来源在10年中分别以每年30.9、23.2和39.8%的人口调整增长率(所有P均<0.001)。 AF消融的增长显着高于PCIs(对于AIHW和MA来源,P <0.001)和所有心血管手术(AIHW:30.9 vs. 3.8%/年,P <0.001)。结论在澳大利亚提供基于导管的AF消融服务在过去十年中呈指数增长。它的年增长率超过了PCIs和所有心血管手术的增长率。考虑到房颤的流行,这些数据对评估房颤消融服务的基础设施,培训和资金的充足性的公共卫生政策具有至关重要的意义。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号